1. Home
  2. BNZI vs ONCO Comparison

BNZI vs ONCO Comparison

Compare BNZI & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$3.47

Market Cap

4.9M

Sector

N/A

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$1.22

Market Cap

755.3K

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
ONCO
Founded
2016
2018
Country
United States
United States
Employees
34
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
755.3K
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BNZI
ONCO
Price
$3.47
$1.22
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$24.00
N/A
AVG Volume (30 Days)
2.1M
5.8M
Earning Date
05-14-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.80
EPS
N/A
N/A
Revenue
N/A
$815,371.00
Revenue This Year
$41.28
N/A
Revenue Next Year
$0.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.07
52 Week High
$8.10
$7.65

Technical Indicators

Market Signals
Indicator
BNZI
ONCO
Relative Strength Index (RSI) 52.86 65.64
Support Level $0.98 $0.42
Resistance Level $3.70 $1.87
Average True Range (ATR) 1.10 0.06
MACD 0.01 0.05
Stochastic Oscillator 41.77 92.49

Price Performance

Historical Comparison
BNZI
ONCO

About BNZI Banzai International Inc.

Banzai International Inc is a Software as a Service (SaaS) company operating in the marketing technology (MarTech) industry. The group provides customers with tools to help them market and sell with greater efficiency and impact. Its customers include Amazon, Dell, Salesforce, Aflac, Thermo Fisher Scientific, RBC Wealth Management, Fitch Group, and many other brands. The Company has three reportable operating segments: Banzai Operating Co, Inc., OpenReel, and Vidello. Its segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions, including video production and editing, for businesses of all sizes. Geographically, it operates in the Americas, Europe, the Middle East and Africa (EMEA), and the Asia Pacific.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Share on Social Networks: